Issue 1/2009
Content (20 Articles)
Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali
Zana C Somda, Martin I Meltzer, Helen N Perry, Nancy E Messonnier, Usman Abdulmumini, Goitom Mebrahtu, Massambou Sacko, Kandioura Touré, Salimata Ouédraogo Ki, Tuoyo Okorosobo, Wondimagegnehu Alemu, Idrissa Sow
Cost effectiveness of community-based therapeutic care for children with severe acute malnutrition in Zambia: decision tree model
Max O Bachmann
The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis
Philip Ayieko, Angela O Akumu, Ulla K Griffiths, Mike English
Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States
Nicolas M Furiak, Haya Ascher-Svanum, Robert W Klein, Lee J Smolen, Anthony H Lawson, Robert R Conley, Steven D Culler
Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia
Pascalina Chanda, Marianela Castillo-Riquelme, Felix Masiye
Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia
Asfaw Demissie Bikilla, Degu Jerene, Bjarne Robberstad, Bernt Lindtjorn
Single food focus dietary guidance: lessons learned from an economic analysis of egg consumption
Jordana K Schmier, Leila M Barraj, Nga L Tran
Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial
Filip Smit, Godelief Willemse, Peter Meulenbeek, Marc Koopmanschap, Anton van Balkom, Philip Spinhoven, Pim Cuijpers
Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective
Werner A Scherbaum, Gordon Goodall, Katrina M Erny-Albrecht, Massimo Massi-Benedetti, Erland Erdmann, William J Valentine
Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina
Adolfo Rubinstein, Sebastián García Martí, Alberto Souto, Daniel Ferrante, Federico Augustovski
Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example
Douglas E Faries, Allen W Nyhuis, Haya Ascher-Svanum
Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain
Garry R Barton, Tracey H Sach, Anthony J Avery, Michael Doherty, Claire Jenkinson, Kenneth R Muir
Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia
Asfaw Demissie Bikilla, Degu Jerene, Bjarne Robberstad, Bernt Lindtjørn
Cost-Effectiveness and Resource Allocation (CERA) – directions for the future
Rob Baltussen, Arnab Acharya, Kathryn Antioch, Dan Chisholm, Richard Grieve, Joses Kirigia, Tessa Tan Torres-Edejer, Damian G Walker, David Evans
Multidimensional evaluation of performance: experimental application of the balanced scorecard in Ferrara university hospital
Adriano Verzola, Roberto Bentivegna, Gianni Carandina, Lucio Trevisani, Pasquale Gregorio, Alberto Mandini
Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia
Lumbwe Chola, Bjarne Robberstad
Medical net cost of low alcohol consumption - a cause to reconsider improved health as the link between alcohol and wage?
Johan Jarl, Ulf G Gerdtham, Klara Hradilova Selin
Can economic evaluation in telemedicine be trusted? A systematic review of the literature
Trine S Bergmo
The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan
Nisso Kasymova, Benjamin Johns, Benusrat Sharipova
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Feng Xie, Gord Blackhouse, Nazila Assasi, Kathryn Gaebel, Diana Robertson, Ron Goeree